News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Economic Considerations for the Treatment of Opioid and Alcohol Dependence

Cost and Utilization Outcomes of Opioid-Dependence Treatments

ByOnur Baser, PhD, MS,Mady Chalk, PhD,David A. Fiellin, MD,David R. Gastfriend, MD

June 17th 2011

Alcohol Dependence Treatments: Comprehensive Healthcare Costs, Utilization Outcomes, and Pharmacotherapy Persistence

ByOnur Baser, PhD, MS,Mady Chalk, PhD,Richard Rawson, PhD,David R. Gastfriend, MD

June 17th 2011

Extended-Release Naltrexone for Alcohol Dependence: Persistence and Healthcare Costs and Utilization

ByWilliam C. Bryson, MD, MPH,K. John McConnell, PhD,P. Todd Korthuis, MD, MPH,Dennis McCarty, PhD

June 17th 2011

Utilization Patterns of Extended-Release Naltrexone for Alcohol Dependence

BySaira Jan, PharmD,Patrick Gill, RPh,Ami S. Borawala, PharmD

June 17th 2011

Economic Considerations for the Treatment of Opioid and Alcohol Dependence: A Managed Care Perspective

ByJeffrey D. Dunn, PharmD, MBA, Formulary,Contract Manager, SelectHealth

June 16th 2011

Participating Faculty: Economic Considerations for the Treatment of Opioid and Alcohol Dependence

By

June 16th 2011

Trending on AJMC

Medicaid Work Requirements Mirror Programs in Georgia, Arkansas: Ciara Zachary, PhD, MPH

FDA Approves Sevabertinib for Nonsquamous NSCLC

Herbal Use Linked to Lower Autoantibodies in Dermatomyositis

Quick Responses May Boost Adherence to Remibrutinib in CSU: Michael J. Palumbo, MD

How Effective and Safe Are GLP-1s for Weight Loss?

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.